Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing
Augmented renal clearance (ARC) is a manifestation of enhanced renal function seen in critically ill patients. The use of regular unadjusted doses of renally eliminated drugs in patients with ARC might lead to therapy failure. The purpose of this scoping review was to provide and up-to-date summary...
Main Authors: | Sherif Hanafy Mahmoud, Chen Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/9/3/36 |
Similar Items
-
Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factors
by: Lama H. Nazer, et al.
Published: (2021-04-01) -
Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
by: Thibaud Besnard, et al.
Published: (2019-01-01) -
Impact of augmented renal clearance on enoxaparin therapy in critically ill patients
by: Hala Ezzat Mohamed Abdel El Naeem, et al.
Published: (2017-01-01) -
Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
by: Abdulaziz S. Almulhim, et al.
Published: (2020-06-01) -
Augmented Renal Clearance and How to Augment Antibiotic Dosing
by: Iris H. Chen, et al.
Published: (2020-07-01)